The Joint Corp. (JYNT) 10-Q 12 May 17 2017 Q1 Quarterly report Financial data

Document And Entity Information

Document And Entity Information - shares	3 Months Ended
	Mar. 31, 2017	May 05, 2017
Document Information [Line Items]
Entity Registrant Name	JOINT Corp
Entity Central Index Key	1,612,630
Trading Symbol	jynt
Current Fiscal Year End Date	--12-31
Entity Filer Category	Smaller Reporting Company
Entity Current Reporting Status	Yes
Entity Voluntary Filers	No
Entity Well-known Seasoned Issuer	No
Entity Common Stock, Shares Outstanding (in shares)		13,082,531
Document Type	10-Q
Document Period End Date	Mar. 31, 2017
Document Fiscal Year Focus	2,017
Document Fiscal Period Focus	Q1
Amendment Flag	false

Condensed Consolidated Balance

Condensed Consolidated Balance Sheets (Current Period Unaudited) - USD ($)	Mar. 31, 2017	Dec. 31, 2016
Current assets:
Cash and cash equivalents	$ 2,676,607	$ 3,009,864
Restricted cash	312,551	334,394
Accounts receivable, net	1,189,132	1,021,733
Income taxes receivable	3,054	42,014
Notes receivable - current portion	30,818	40,826
Deferred franchise costs - current portion	686,873	748,300
Prepaid expenses and other current assets	893,520	499,525
Total current assets	5,792,555	5,696,656
Property and equipment, net	4,360,900	4,724,706
Deferred franchise costs, net of current portion	738,258	836,350
Intangible assets, net	2,164,066	2,338,922
Goodwill	2,750,338	2,750,338
Deposits and other assets	667,021	707,889
Total assets	16,473,138	17,054,861
Current liabilities:
Accounts payable	1,089,176	1,054,946
Accrued expenses	161,542	299,997
Co-op funds liability	95,007	73,246
Payroll liabilities	397,095	750,421
Notes payable - current portion	168,000	331,500
Deferred rent - current portion	148,564	215,450
Deferred revenue - current portion	2,866,880	3,077,430
Other current liabilities	54,479	60,894
Total current liabilities	4,980,743	5,863,884
Revolving credit - notes payable	1,000,000
Deferred rent, net of current portion	907,723	1,400,790
Deferred revenue, net of current portion	2,695,729	2,231,712
Deferred tax liability	156,920	120,700
Other liabilities	1,242,332	512,362
Total liabilities	10,983,447	10,129,448
Commitments and contingencies
Stockholders' equity:
Series A preferred stock, $0.001 par value; 50,000 shares authorized, 0 issued and outstanding, as of March 31, 2017, and December 31, 2016
Common stock, $0.001 par value; 20,000,000 shares authorized, 13,371,535 shares issued and 13,075,031 shares outstanding as of March 31, 2017 and 13,317,393 shares issued and 13,020,889 outstanding as of December 31, 2016	13,371	13,317
Additional paid-in capital	36,609,876	36,398,588
Treasury stock 296,504 shares as of March 31, 2017 and December 31, 2016	(503,118)	(503,118)
Accumulated deficit	(30,630,438)	(28,983,374)
Total stockholders' equity	5,489,691	6,925,413
Total liabilities and stockholders' equity	$ 16,473,138	$ 17,054,861

Condensed Consolidated Balance3

Condensed Consolidated Balance Sheets (Current Period Unaudited) (Parentheticals) - $ / shares	Mar. 31, 2017	Dec. 31, 2016
Series A preferred stock, par value (in dollars per share)	$ 0.001	$ 0.001
Series A preferred stock, shares authorized (in shares)	50,000	50,000
Series A preferred stock, shares issued (in shares)	0	0
Series A preferred stock, shares outstanding (in shares)	0	0
Common stock, par value (in dollars per share)	$ 0.001	$ 0.001
Common stock, shares authorized (in shares)	20,000,000	20,000,000
Common stock, shares issued (in shares)	13,371,535	13,317,393
Common stock, shares outstanding (in shares)	13,075,031	13,020,889

Condensed Consolidated Statemen

Condensed Consolidated Statements of Operations (Unaudited) - USD ($)	3 Months Ended
	Mar. 31, 2017	Mar. 31, 2016
Revenues:
Revenues and management fees from company clinics	$ 2,515,601	$ 1,658,553
Royalty fees	1,706,073	1,368,831
Franchise fees	449,500	514,800
Advertising fund revenue	598,436	265,721
IT related income and software fees	267,013	221,134
Regional developer fees	76,896	147,537
Other revenues	60,338	88,460
Total revenues	5,673,857	4,265,036
Cost of revenues:
Franchise cost of revenues	683,243	694,735
IT cost of revenues	58,861	45,228
Total cost of revenues	742,104	739,963
Selling and marketing expenses	958,706	738,683
Depreciation and amortization	577,987	575,544
General and administrative expenses	4,564,079	5,692,056
Total selling, general and administrative expenses	6,100,772	7,006,283
Loss on disposition or impairment	417,971
Loss from operations	(1,586,990)	(3,481,210)
Other (expense) income, net	(19,465)	473
Loss before income tax expense	(1,606,455)	(3,480,737)
Income tax expense	(40,609)	(44,397)
Net loss and comprehensive loss	$ (1,647,064)	$ (3,525,134)
Loss per share:
Basic and diluted loss per share (in dollars per share)	$ (0.13)	$ (0.28)
Basic and diluted weighted average shares (in shares)	13,042,595	12,567,901

Condensed Consolidated Stateme5

Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)	3 Months Ended
	Mar. 31, 2017	Mar. 31, 2016
Cash flows from operating activities:
Net loss	$ (1,647,064)	$ (3,525,134)
Adjustments to reconcile net loss to net cash used in operating activities:
Net franchise fees recognized upon termination of franchise agreements		(41,100)
Depreciation and amortization	577,987	575,544
Loss on disposition or impairment	417,971
Deferred income taxes	36,220
Stock based compensation expense	95,065	197,669
Changes in operating assets and liabilities:
Restricted cash	21,843	(71,985)
Accounts receivable	(214,860)	(902,190)
Income taxes receivable	38,960	32,021
Prepaid expenses and other current assets	(393,995)	(78,997)
Deferred franchise costs	159,519	121,602
Deposits and other assets	40,868	(3,339)
Accounts payable	34,230	(1,229,146)
Accrued expenses	(138,455)	(234,291)
Co-op funds liability	21,761	(96,546)
Payroll liabilities	(353,326)	(829,933)
Other liabilities	102,459	9,790
Deferred rent	(309,367)	628,181
Deferred revenue	253,467	(311,874)
Net cash used in operating activities	(1,256,717)	(5,759,728)
Cash flows from investing activities:
Reacquisition and termination of regional developer rights		(275,000)
Purchase of property and equipment	(39,325)	(287,942)
Payments received on notes receivable	10,008	17,258
Net cash used in investing activities	(29,317)	(545,684)
Cash flows from financing activities:
Borrowings on revolving credit note payable	1,000,000
Issuance of common stock, offering costs adjustment		(1,042)
Proceeds from exercise of stock options	116,277	1,600
Repayments on notes payable	(163,500)	(120,500)
Net cash provided by (used in) financing activities	952,777	(119,942)
Net decrease in cash	(333,257)	(6,425,354)
Cash at beginning of period	3,009,864	16,792,850
Cash at end of period	$ 2,676,607	$ 10,367,496

Supplemental Disclosure of Non-

Supplemental Disclosure of Non-cash Information	3 Months Ended
	Mar. 31, 2017
Notes to Financial Statements
Cash Flow, Supplemental Disclosures [Text Block]	During the three March 31, 2017 2016, $5,875 $3,625, three March 31, 2017 2016, $30,161 $2,648, Supplemental disclosure of non-cash activity: As of March 31, 2016, $796,581 $147,186

Note 1 - Nature of Operations a

Note 1 - Nature of Operations and Summary of Significant Accounting Policies	3 Months Ended
	Mar. 31, 2017
Notes to Financial Statements
Organization, Consolidation and Presentation of Financial Statements Disclosure and Significant Accounting Policies [Text Block]	Note 1: Basis of Presentation These unaudited financial statements represent the condensed consolidated financial statements of The Joint Corp. (“The Joint”) and its wholly owned subsidiary The Joint Corporate Unit No. 1, 10 March 31, 2017 2016 March 31, 2017 2016 Principles of Consolidation The accompanying condensed consolidated financial statements include the accounts of The Joint Corp. and its wholly owned subsidiary, The Joint Corporate Unit No. 1, All significant intercompany accounts and transactions between The Joint Corp. and its subsidiary have been eliminated in consolidation. Comprehensive Loss Net loss and comprehensive loss are the same for the three March 31, 2017 2016. Nature of Operations The Joint, a Delaware corporation, was formed on March 10, 2010 The following table summarizes the number of clinics in operation under franchise agreements and as company-owned or managed clinics for the three March 31, 2017 2016: Three Months Ended March 31, Franchised clinics: 2017 2016 Clinics open at beginning of period 309 265 Opened or purchased during the period 18 14 Acquired during the period - - Closed during the period (1 ) (2 ) Clinics in operation at the end of the period 326 277 March 31, Company-owned or managed clinics: 2017 2016 Clinics open at beginning of period 61 47 Opened during the period - 7 Acquired during the period - - Closed or sold during the period (14 ) - Clinics in operation at the end of the period 47 54 Total clinics in operation at the end of the period 373 331 Clinic licenses sold but not yet developed 107 146 Variable Interest Entities An entity deemed to hold the controlling interest in a voting interest entity or deemed to be the primary beneficiary of a variable interest entity (“VIE”) is required to consolidate the VIE in its financial statements. An entity is deemed to be the primary beneficiary of a VIE if it has both of the following characteristics: (a) the power to direct the activities of a VIE that most significantly impact the VIE's economic performance and (b) the obligation to absorb the majority of losses of the VIE or the right to receive the majority of benefits from the VIE. Investments where the Company does not hold the controlling interest and is not the primary beneficiary are accounted for under the equity method. Certain states in which the Company manages clinics regulate the practice of chiropractic care and require that chiropractic services be provided by legal entities organized under state laws as professional corporations or PCs. Such PCs are VIEs. In these states, the Company has entered into management services agreements with such PCs under which the Company provides, on an exclusive basis, all non-clinical services of the chiropractic practice. The Company has analyzed its relationship with the PCs and has determined that the Company does not have the power to direct the activities of the PCs. As such, the activities of the PCs are not included in the Company’s condensed consolidated financial statements Cash and Cash Equivalents The Company considers all highly liquid instruments purchased with an original maturity of three no March 31, 2017 December 31, 2016. Restricted Cash Restricted cash relates to cash that franchisees and company-owned or managed clinics contribute to the Company’s National Marketing Fund and cash that franchisees provide to various voluntary regional Co-Op Marketing Funds. Cash contributed by franchisees to the National Marketing Fund is to be used in accordance with the Company’s Franchise Disclosure Document with a focus on regional and national marketing and advertising. Concentrations of Credit Risk From time to time, the Company grants credit in the normal course of business to franchisees and PCs related to the collection of royalties and other operating revenues. The Company periodically performs credit analysis and monitors the financial condition of the franchisees and PCs to reduce credit risk. As of March 31, 2017 December 31, 2016, three five 28% 24%, not 10% three March 31, 2017 2016. Accounts Receivable Accounts receivable represent amounts due from franchisees for initial franchise fees and royalty fees, working capital advances due from PCs, and tenant March 31, 2017 December 31, 2016, $131,830 Deferred Franchise Costs Deferred franchise costs represent commissions that are paid in conjunction with the sale of a franchise and are recognized as an expense when the respective revenue is recognized, which is generally upon the opening of a clinic. Property and Equipment Property and equipment are stated at cost or for property acquired as part of franchise acquisitions at fair value at the date of closing. Depreciation is computed using the straight-line method over estimated useful lives of three seven Maintenance and repairs are charged to expense as incurred; major renewals and improvements are capitalized. When items of property or equipment are sold or retired, the related cost and accumulated depreciation are removed from the accounts and any gain or loss is included in income. Software Developed The Company capitalizes certain software development costs. These capitalized costs are primarily related to proprietary software used by clinics for operations and by the Company for the management of operations. Costs incurred in the preliminary stages of development are expensed as incurred. Once an application has reached the development stage, internal and external costs, if direct, are capitalized as assets in progress until the software is substantially complete and ready for its intended use. Capitalization ceases upon completion of all substantial testing. The Company also capitalizes costs related to specific upgrades and enhancements when it is probable the expenditures will result in additional functionality. Software developed is recorded as part of property and equipment. Maintenance and training costs are expensed as incurred. Internal use software is amortized on a straight line basis over its estimated useful life, generally five Intangible Assets Intangible assets consist primarily of re-acquired franchise and regional developer rights and customer relationships. The Company amortizes the fair value of re-acquired franchise rights over the remaining contractual terms of the re-acquired franchise rights at the time of the acquisition, which range from six eight seven two Goodwill Goodwill consists of the excess of the purchase price over the fair value of tangible and identifiable intangible assets acquired in the acquisitions. Goodwill and intangible assets deemed to have indefinite lives are not amortized but are subject to annual impairment tests. As required, the Company performs an annual impairment test of goodwill as of the first fourth No three March 31, 2017 2016. Long-Lived Assets The Company reviews its long-lived assets for impairment whenever events or changes in circumstances indicate that the carrying amount of the asset may No three March 31, 2017 2016. Advertising Fund The Company has established an advertising fund for national/regional marketing and advertising of services offered by its clinics. The monthly marketing fee is 2% Co-Op Marketing Funds Some franchises have established regional Co-Ops for advertising within their local and regional markets. The Company maintains a custodial relationship under which the marketing funds collected are segregated and used for the purposes specified by the Co-Ops’ officers. The marketing funds are included in restricted cash on the Company’s condensed consolidated balance sheets. Accounting for Costs Associated with Exit or Disposal Activities The Company recognizes a liability for the cost associated with an exit or disposal activity that is measured initially at its fair value in the period in which the liability is incurred. Costs to terminate an operating lease or other contracts are (a) costs to terminate the contract before the end of its term or (b) costs that will continue to be incurred under the contract for its remaining term without economic benefit to the entity. A liability for costs that will continue to be incurred under a contract for its remaining term without economic benefit to the entity is recognized at the cease-use date. In periods subsequent to initial measurement, changes to the liability are measured using the credit adjusted risk-free rate that was used to measure the fair value of the liability initially. The cumulative effect of a change resulting from a revision to either the timing or the amount of estimated cash flows is recognized as an adjustment to the liability in the period of the change. In the three March 31, 2017 $0.7 Deferred Rent The Company leases office space for its corporate offices and company-owned or managed clinics under operating leases, which may tenant Revenue Recognition The Company generates revenue through initial franchise fees, regional developer fees, royalties, advertising fund revenue, IT related income, and computer software fees, and from its company-owned and managed clinics. Franchise Fees. ten Regional Developer Fees 2011, $7,250 25% $14,500 $19,950 3% For the three March 31, 2017, three $650,000, Revenues and Management Fees from Company Clinics. Royalties. 7% 2% two IT Related Income and Software Fees. Advertising Costs Advertising costs are expensed as incurred. Advertising expenses were $286,415 $422,098 three March 31, 2017 2016, Income Taxes The Company uses an estimated annual effective tax rate method in computing its interim tax provision. This effective tax rate is based on forecasted annual pre-tax income, permanent tax differences and statutory tax rates. Deferred income taxes are recognized for differences between the basis of assets and liabilities for financial statement and income tax purposes. The differences relate principally to depreciation of property and equipment, amortization of goodwill, accounting for leases, and treatment of revenue for franchise fees and regional developer fees collected. Deferred tax assets and liabilities represent the future tax consequence for those differences, which will either be taxable or deductible when the assets and liabilities are recovered or settled. Deferred taxes are also recognized for operating losses that are available to offset future taxable income. Valuation allowances are established when necessary to reduce deferred tax assets to the amount expected to be realized. The Company accounts for uncertainty in income taxes by recognizing the tax benefit or expense from an uncertain tax position only if it is more likely than not that the tax position will be sustained upon examination by the taxing authorities, based on the technical merits of the position. The Company measures the tax benefits and expenses recognized in the condensed consolidated financial statements from such a position based on the largest benefit that has a greater than 50% At March 31, 2017 December 31, 2016, $40,000 $27,000 2012 2013 Loss per Common Share Basic loss per common share is computed by dividing the net loss by the weighted-average number of common shares outstanding during the period. Diluted loss per common share is computed by giving effect to all potentially dilutive common shares including preferred stock, restricted stock, and stock options. Three Months Ended March 31, 2017 2016 Net loss $ (1,647,064 ) $ (3,525,134 ) Weighted average common shares outstanding - basic 13,042,595 12,567,901 Effect of dilutive securities: Stock options - - Weighted average common shares outstanding - diluted 13,042,595 12,567,901 Basic and diluted loss per share $ (0.13 ) $ (0.28 ) The following table summarizes the potential shares of common stock that were excluded from diluted net loss per share, because the effect of including these potential shares was anti-dilutive: Three Months Ended March 31, 2017 2016 Unvested restricted stock 80,070 292,466 Stock options 916,915 768,625 Warrants 90,000 90,000 Stock-Based Compensation The Company accounts for share based payments by recognizing compensation expense based upon the estimated fair value of the awards on the date of grant. The Company determines the estimated grant-date fair value of restricted shares using quoted market prices and the grant-date fair value of stock options using the Black-Scholes option pricing model. In order to calculate the fair value of the options, certain assumptions are made regarding the components of the model, including the estimated fair value of underlying common stock, risk-free interest rate, volatility, expected dividend yield and expected option life. Changes to the assumptions could cause significant adjustments to the valuation. The Company recognizes compensation costs ratably over the period of service using the straight-line method. Use of Estimates The preparation of the condensed consolidated financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the amounts reported in the condensed consolidated financial statements and accompanying notes. Actual results could differ from those estimates. Items subject to significant estimates and assumptions include the allowance for doubtful accounts, share-based compensation arrangements, fair value of stock options, useful lives and realizability of long-lived assets, classification of deferred revenue and deferred franchise costs, uncertain tax positions, realizability of deferred tax assets, impairment of goodwill and intangible assets and purchase price allocations. Recent Accounting Pronouncements In May, 2014, 2014 09, Revenue from Contracts with Customers January 1, 2018. 2014 09 2014 09 first 2017. In February 2016, 2016 02, Leases (Topic 842). December 31, 2018. In March 2016, 2016 09, Compensation—Stock Compensation (Topic 718): January 1, 2017. In April 2016, 2016 10, Revenue from Contracts with Customers (Topic 606): two 606: 1) 2) 2014 09. In May 2016, 2016 12, Revenue from Contracts with Customers (Topic 606): 2014 09. In August 2016, 2016 15, “Statement of Cash Flows (Topic 230): December 15, 2017. In November 2016, 2016 18, Statement of Cash Flows (Topic 230): December 15, 2017, In January 2017, 2017 01, Business Combinations (Topic 805): December 15, 2017, In January 2017, 2017 04, Intangibles - Goodwill and Other (Topic 350): 2” December 15, 2019.

Note 2 - Notes Receivable

Note 2 - Notes Receivable	3 Months Ended
	Mar. 31, 2017
Notes to Financial Statements
Loans, Notes, Trade and Other Receivables Disclosure [Text Block]	Note 2: Effective July 2012, $90,000 6% fifty four forty two August 2013. January 2017 Effective July 2015, two $10,000 $29,925 24 September 1, 2015 August 1, 2017. Effective May 2016, three three $7,500 six May 1, 2017 October 1, 2017. The net outstanding balance of the notes as of March 31, 2017 December 31, 2016 $30,818 $40,826,

Note 3 - Property and Equipment

Note 3 - Property and Equipment	3 Months Ended
	Mar. 31, 2017
Notes to Financial Statements
Property, Plant and Equipment Disclosure [Text Block]	Note 3: Property and equipment consists of the following: March 31, December 31, 2017 2016 Office and computer equipment $ 1,099,747 $ 1,083,039 Leasehold improvements 5,085,366 5,085,366 Software developed 1,046,823 891,192 7,231,936 7,059,597 Accumulated depreciation (2,969,302 ) (2,566,172 ) 4,262,634 4,493,425 Construction in progress 98,266 231,281 $ 4,360,900 $ 4,724,706 Depreciation expense was $403,131 $401,867 three March 31, 2017 2016, In December, 2016, 14 December, 2016, $2.4 2016 first 2017

Note 4 - Fair Value Considerati

Note 4 - Fair Value Consideration	3 Months Ended
	Mar. 31, 2017
Notes to Financial Statements
Fair Value Disclosures [Text Block]	Note 4: The Company’s financial instruments include cash, restricted cash, accounts receivable, notes receivable, accounts payable, accrued expenses and notes payable. The carrying amounts of its financial instruments approximate their fair value due to their short maturities. The Company does not use derivative financial instruments to hedge exposures to cash-flow, market or foreign-currency risks. Authoritative guidance defines fair value as the price that would be received to sell an asset or paid to transfer a liability (an exit price) in an orderly transaction between market participants at the measurement date. The guidance establishes a hierarchy for inputs used in measuring fair value that maximizes the use of observable inputs and minimizes the use of unobservable inputs by requiring that the most observable inputs be used when available. Observable inputs are inputs that market participants would use in pricing the asset or liability, developed based on market data obtained from sources independent of the Company. Unobservable inputs are inputs that reflect the Company’s assumptions of what market participants would use in pricing the asset or liability developed based on the best information available in the circumstances. The hierarchy is broken down into three Level 1: Observable inputs such as quoted prices in active markets; Level 2: Inputs, other than the quoted prices in active markets, that are observable either directly or indirectly; and Level 3: Unobservable inputs in which there is little or no market data, which require the reporting entity to develop its own assumptions. As of March 31, 2017 December 31, 2016, not 1, 2 3.

Note 5 - Intangible Assets

Note 5 - Intangible Assets	3 Months Ended
	Mar. 31, 2017
Notes to Financial Statements
Intangible Assets Disclosure [Text Block]	Note 5: Intangible assets consist of the following: As of March 31, 2017 Gross Carrying Accumulated Net Carrying Amount Amortization Value Amortized intangible assets: Reacquired franchise rights $ 1,911,750 $ 515,136 $ 1,396,614 Customer relationships 701,000 580,584 120,416 Reacquired development rights 923,250 276,214 647,036 $ 3,536,000 $ 1,371,934 $ 2,164,066 Amortization expense was $174,856 $173,677 three March 31, 2017 2016, Estimated amortization expense for 2017 2017 $ 404,025 2018 439,589 2019 413,256 2020 413,256 2021 348,034 Thereafter 145,906 Total $ 2,164,066

Note 6 - Debt

Note 6 - Debt	3 Months Ended
	Mar. 31, 2017
Notes to Financial Statements
Debt Disclosure [Text Block]	Note 6: Notes Payable During 2015, 12 $800,350 1.5% 5.25% February, 2017. During 2016, two $186,000 4.25% May, 2017. Maturities of notes payable are as follows as of March 31, 2017: 2017 $ 168,000 Thereafter - Total $ 168,000 Credit and Security Agreement On January 3, 2017, $5,000,000 10% $200,000. $25,000. December 2019, March 31, 2017, $1,000,000 $5,000,000

Note 7 - Equity

Note 7 - Equity	3 Months Ended
	Mar. 31, 2017
Notes to Financial Statements
Stockholders' Equity Note Disclosure [Text Block]	Note 7: Stock Options In the three March 31, 2017, 40,000 $2.65 $3.11. Upon the completion of the Company’s IPO in November 2014, 10 The Company has computed the fair value of all options granted during the three March 31, 2017 2016, Three Months Ended March 31, 2017 2016 Expected volatility 42% 44% - 45% Expected dividends None None Expected term (years) 7 7 Risk-free rate 2.10% to 2.14% 1.50% - 1.68% Forfeiture rate 20% 20% The information below summarizes the stock options activity: Number of Weighted Weighted Weighted Outstanding at December 31, 2016 953,075 $ 3.66 $ 1.86 6.9 Granted at market price 40,000 3.00 Exercised (59,142 ) 1.20 Cancelled (17,018 ) 5.10 Outstanding at March 31, 2017 916,915 $ 3.76 $ 1.78 7.0 Exercisable at March 31, 2017 345,855 $ 4.59 $ 2.24 4.4 The intrinsic value of the Company’s stock options outstanding was $1,021,554 March 31, 2017. For the three March 31, 2017 2016, $51,038 $107,506, March 31, 2017 $686,052, 3.1 Restricted Stock The information below summaries the restricted stock activity: Restricted Stock Awards Shares Outstanding at December 31, 2016 92,415 Awards granted - Awards vested - Awards forfeited (12,345 ) Outstanding at March 31, 2017 80,070 For the three March 31, 2017 2016, $44,027 $90,163, March 31, 2017 $73,672 1.5 Treasury Stock In December, 2013, first March 10, 2010 534,000 $0.45 $240,000 534,000 $791,638, 8 Year 1 $ 0.56 Year 2 $ 0.68 Year 3 $ 0.84 Year 4 $ 1.03 Year 5 $ 1.28 Year 6 $ 1.59 Year 7 $ 1.97 Year 8 $ 2.45 Consideration given in the form of the option was valued using a Binomial Lattice-Based model resulting in a fair value of $1.03 $551,638. During December, 2016, 250,872 $210,000. $113,000 $259,000, $162,000.

Note 8 - Income Taxes

Note 8 - Income Taxes	3 Months Ended
	Mar. 31, 2017
Notes to Financial Statements
Income Tax Disclosure [Text Block]	Note 8: During the three March 31, 2017 2016, $41,000 $44,000,

Note 9 - Related Party Transact

Note 9 - Related Party Transactions	3 Months Ended
	Mar. 31, 2017
Notes to Financial Statements
Related Party Transactions Disclosure [Text Block]	Note 9: The Company entered into consulting and legal agreements with certain common stockholders related to services performed for the operations and transaction related activities of the Company. Amounts paid to or for the benefit of these stockholders was approximately $52,000 $110,000 three March 31, 2017 2016,

Note 10 - Commitments and Conti

Note 10 - Commitments and Contingencies	3 Months Ended
	Mar. 31, 2017
Notes to Financial Statements
Commitments and Contingencies Disclosure [Text Block]	Note 10: Operating Leases The Company leases its corporate office space and the space for each of the company-owned or managed clinics in the portfolio. Total rent expense for the three March 31, 2017 2016 $744,295 $752,495, Future minimum annual lease payments are as follows: 2017 (remaining) $ 1,814,011 2018 1,855,661 2019 1,536,117 2020 1,264,664 2021 1,122,612 Thereafter 3,923,358 Total $ 11,516,423

Note 11 - Segment Reporting

Note 11 - Segment Reporting	3 Months Ended
	Mar. 31, 2017
Notes to Financial Statements
Segment Reporting Disclosure [Text Block]	Note 11: An operating segment is defined as a component of an enterprise for which discrete financial information is available and is reviewed regularly by the Chief Operating Decision Maker (“CODM”), to evaluate performance and make operating decisions. The Company has identified its CODM as the Chief Executive Officer. The Company has two March 31, 2017, 47 March 31, 2017, 326 two The tables below present financial information for the Company’s two Three Months Ended March 31, 2017 2016 Revenues: Corporate clinics $ 2,497 $ 1,659 Franchise operations 3,177 2,606 Total revenues $ 5,674 $ 4,265 Segment operating (loss) income: Corporate clinics $ (599 ) $ (1,694 ) Franchise operations 1,351 989 Total segment operating (loss) income $ 752 $ (705 ) Depreciation and amortization: Corporate clinics $ 444 $ 493 Franchise operations - - Corporate administration 134 83 Total depreciation and amortization $ 578 $ 576 Reconciliation of total segment operating income (loss) to consolidated earnings (loss) before income taxes (in thousands): Total segment operating (loss) income $ 752 $ (705 ) Unallocated corporate (2,339 ) (2,776 ) Consolidated loss from operations (1,587 ) (3,481 ) Other (expense) income, net (19 ) - Loss before income tax expense $ (1,606 ) $ (3,481 ) March 31, December 31, 2017 2016 Segment assets: Corporate clinics $ 10,301 $ 10,481 Franchise operations 1,894 2,003 Total segment assets $ 12,195 $ 12,484 Unallocated cash and cash equivalents and restricted cash $ 2,989 $ 3,344 Unallocated property and equipment 680 781 Other unallocated assets 609 446 Total assets $ 16,473 $ 17,055 “Unallocated cash and cash equivalents and restricted cash” relates primarily to corporate cash and cash equivalents and restricted cash (see Note 1), The Company reclassified approximately $545,000 December 31, 2016

Note 12 - Subsequent Events

Note 12 - Subsequent Events	3 Months Ended
	Mar. 31, 2017
Notes to Financial Statements
Subsequent Events [Text Block]	Note 12: On April 29, 2017, $320,000. 32 ten 10% 42 36 November 1, 2017 October 1, 2020.

Significant Accounting Policies

Significant Accounting Policies (Policies)	3 Months Ended
	Mar. 31, 2017
Accounting Policies [Abstract]
Consolidation, Policy [Policy Text Block]	Principles of Consolidation The accompanying condensed consolidated financial statements include the accounts of The Joint Corp. and its wholly owned subsidiary, The Joint Corporate Unit No. 1, All significant intercompany accounts and transactions between The Joint Corp. and its subsidiary have been eliminated in consolidation.
Comprehensive Income, Policy [Policy Text Block]	Comprehensive Loss Net loss and comprehensive loss are the same for the three March 31, 2017 2016.
Nature of Operations Policy [Policy Text Block]	Nature of Operations The Joint, a Delaware corporation, was formed on March 10, 2010 The following table summarizes the number of clinics in operation under franchise agreements and as company-owned or managed clinics for the three March 31, 2017 2016: Three Months Ended March 31, Franchised clinics: 2017 2016 Clinics open at beginning of period 309 265 Opened or purchased during the period 18 14 Acquired during the period - - Closed during the period (1 ) (2 ) Clinics in operation at the end of the period 326 277 March 31, Company-owned or managed clinics: 2017 2016 Clinics open at beginning of period 61 47 Opened during the period - 7 Acquired during the period - - Closed or sold during the period (14 ) - Clinics in operation at the end of the period 47 54 Total clinics in operation at the end of the period 373 331 Clinic licenses sold but not yet developed 107 146
Consolidation, Variable Interest Entity, Policy [Policy Text Block]	Variable Interest Entities An entity deemed to hold the controlling interest in a voting interest entity or deemed to be the primary beneficiary of a variable interest entity (“VIE”) is required to consolidate the VIE in its financial statements. An entity is deemed to be the primary beneficiary of a VIE if it has both of the following characteristics: (a) the power to direct the activities of a VIE that most significantly impact the VIE's economic performance and (b) the obligation to absorb the majority of losses of the VIE or the right to receive the majority of benefits from the VIE. Investments where the Company does not hold the controlling interest and is not the primary beneficiary are accounted for under the equity method. Certain states in which the Company manages clinics regulate the practice of chiropractic care and require that chiropractic services be provided by legal entities organized under state laws as professional corporations or PCs. Such PCs are VIEs. In these states, the Company has entered into management services agreements with such PCs under which the Company provides, on an exclusive basis, all non-clinical services of the chiropractic practice. The Company has analyzed its relationship with the PCs and has determined that the Company does not have the power to direct the activities of the PCs. As such, the activities of the PCs are not included in the Company’s condensed consolidated financial statements
Cash and Cash Equivalents, Policy [Policy Text Block]	Cash and Cash Equivalents The Company considers all highly liquid instruments purchased with an original maturity of three no March 31, 2017 December 31, 2016.
Cash and Cash Equivalents, Restricted Cash and Cash Equivalents, Policy [Policy Text Block]	Restricted Cash Restricted cash relates to cash that franchisees and company-owned or managed clinics contribute to the Company’s National Marketing Fund and cash that franchisees provide to various voluntary regional Co-Op Marketing Funds. Cash contributed by franchisees to the National Marketing Fund is to be used in accordance with the Company’s Franchise Disclosure Document with a focus on regional and national marketing and advertising.
Concentration Risk, Credit Risk, Policy [Policy Text Block]	Concentrations of Credit Risk From time to time, the Company grants credit in the normal course of business to franchisees and PCs related to the collection of royalties and other operating revenues. The Company periodically performs credit analysis and monitors the financial condition of the franchisees and PCs to reduce credit risk. As of March 31, 2017 December 31, 2016, three five 28% 24%, not 10% three March 31, 2017 2016.
Trade and Other Accounts Receivable, Policy [Policy Text Block]	Accounts Receivable Accounts receivable represent amounts due from franchisees for initial franchise fees and royalty fees, working capital advances due from PCs, and tenant March 31, 2017 December 31, 2016, $131,830
Revenue Recognition, Services, Commissions [Policy Text Block]	Deferred Franchise Costs Deferred franchise costs represent commissions that are paid in conjunction with the sale of a franchise and are recognized as an expense when the respective revenue is recognized, which is generally upon the opening of a clinic.
Property, Plant and Equipment, Policy [Policy Text Block]	Property and Equipment Property and equipment are stated at cost or for property acquired as part of franchise acquisitions at fair value at the date of closing. Depreciation is computed using the straight-line method over estimated useful lives of three seven Maintenance and repairs are charged to expense as incurred; major renewals and improvements are capitalized. When items of property or equipment are sold or retired, the related cost and accumulated depreciation are removed from the accounts and any gain or loss is included in income.
Internal Use Software, Policy [Policy Text Block]	Software Developed The Company capitalizes certain software development costs. These capitalized costs are primarily related to proprietary software used by clinics for operations and by the Company for the management of operations. Costs incurred in the preliminary stages of development are expensed as incurred. Once an application has reached the development stage, internal and external costs, if direct, are capitalized as assets in progress until the software is substantially complete and ready for its intended use. Capitalization ceases upon completion of all substantial testing. The Company also capitalizes costs related to specific upgrades and enhancements when it is probable the expenditures will result in additional functionality. Software developed is recorded as part of property and equipment. Maintenance and training costs are expensed as incurred. Internal use software is amortized on a straight line basis over its estimated useful life, generally five
Intangible Assets, Finite-Lived, Policy [Policy Text Block]	Intangible Assets Intangible assets consist primarily of re-acquired franchise and regional developer rights and customer relationships. The Company amortizes the fair value of re-acquired franchise rights over the remaining contractual terms of the re-acquired franchise rights at the time of the acquisition, which range from six eight seven two
Goodwill and Intangible Assets, Goodwill, Policy [Policy Text Block]	Goodwill Goodwill consists of the excess of the purchase price over the fair value of tangible and identifiable intangible assets acquired in the acquisitions. Goodwill and intangible assets deemed to have indefinite lives are not amortized but are subject to annual impairment tests. As required, the Company performs an annual impairment test of goodwill as of the first fourth No three March 31, 2017 2016.
Impairment or Disposal of Long-Lived Assets, Policy [Policy Text Block]	Long-Lived Assets The Company reviews its long-lived assets for impairment whenever events or changes in circumstances indicate that the carrying amount of the asset may No three March 31, 2017 2016.
Advertising Fund, Policy [Policy Text Block]	Advertising Fund The Company has established an advertising fund for national/regional marketing and advertising of services offered by its clinics. The monthly marketing fee is 2%
Cooperative Advertising Policy [Policy Text Block]	Co-Op Marketing Funds Some franchises have established regional Co-Ops for advertising within their local and regional markets. The Company maintains a custodial relationship under which the marketing funds collected are segregated and used for the purposes specified by the Co-Ops’ officers. The marketing funds are included in restricted cash on the Company’s condensed consolidated balance sheets.
Costs Associated with Exit or Disposal Activities or Restructurings, Policy [Policy Text Block]	Accounting for Costs Associated with Exit or Disposal Activities The Company recognizes a liability for the cost associated with an exit or disposal activity that is measured initially at its fair value in the period in which the liability is incurred. Costs to terminate an operating lease or other contracts are (a) costs to terminate the contract before the end of its term or (b) costs that will continue to be incurred under the contract for its remaining term without economic benefit to the entity. A liability for costs that will continue to be incurred under a contract for its remaining term without economic benefit to the entity is recognized at the cease-use date. In periods subsequent to initial measurement, changes to the liability are measured using the credit adjusted risk-free rate that was used to measure the fair value of the liability initially. The cumulative effect of a change resulting from a revision to either the timing or the amount of estimated cash flows is recognized as an adjustment to the liability in the period of the change. In the three March 31, 2017 $0.7
Lessee, Leases [Policy Text Block]	Deferred Rent The Company leases office space for its corporate offices and company-owned or managed clinics under operating leases, which may tenant
Revenue Recognition, Policy [Policy Text Block]	Revenue Recognition The Company generates revenue through initial franchise fees, regional developer fees, royalties, advertising fund revenue, IT related income, and computer software fees, and from its company-owned and managed clinics.
Revenue Recognition, Services, Franchise Fees [Policy Text Block]	Franchise Fees. ten
Regional Developer Fees, Policy [Policy Text Block]	Regional Developer Fees 2011, $7,250 25% $14,500 $19,950 3% For the three March 31, 2017, three $650,000,
Revenues and Management Fees, Policy [Policy Text Block]	Revenues and Management Fees from Company Clinics.
Royalties, Policy [Policy Text Block]	Royalties. 7% 2% two
IT Related Income And Software Fees, Policy [Policy Text Block]	IT Related Income and Software Fees.
Advertising Costs, Policy [Policy Text Block]	Advertising Costs Advertising costs are expensed as incurred. Advertising expenses were $286,415 $422,098 three March 31, 2017 2016,
Income Tax, Policy [Policy Text Block]	Income Taxes The Company uses an estimated annual effective tax rate method in computing its interim tax provision. This effective tax rate is based on forecasted annual pre-tax income, permanent tax differences and statutory tax rates. Deferred income taxes are recognized for differences between the basis of assets and liabilities for financial statement and income tax purposes. The differences relate principally to depreciation of property and equipment, amortization of goodwill, accounting for leases, and treatment of revenue for franchise fees and regional developer fees collected. Deferred tax assets and liabilities represent the future tax consequence for those differences, which will either be taxable or deductible when the assets and liabilities are recovered or settled. Deferred taxes are also recognized for operating losses that are available to offset future taxable income. Valuation allowances are established when necessary to reduce deferred tax assets to the amount expected to be realized. The Company accounts for uncertainty in income taxes by recognizing the tax benefit or expense from an uncertain tax position only if it is more likely than not that the tax position will be sustained upon examination by the taxing authorities, based on the technical merits of the position. The Company measures the tax benefits and expenses recognized in the condensed consolidated financial statements from such a position based on the largest benefit that has a greater than 50% At March 31, 2017 December 31, 2016, $40,000 $27,000 2012 2013
Earnings Per Share, Policy [Policy Text Block]	Loss per Common Share Basic loss per common share is computed by dividing the net loss by the weighted-average number of common shares outstanding during the period. Diluted loss per common share is computed by giving effect to all potentially dilutive common shares including preferred stock, restricted stock, and stock options. Three Months Ended March 31, 2017 2016 Net loss $ (1,647,064 ) $ (3,525,134 ) Weighted average common shares outstanding - basic 13,042,595 12,567,901 Effect of dilutive securities: Stock options - - Weighted average common shares outstanding - diluted 13,042,595 12,567,901 Basic and diluted loss per share $ (0.13 ) $ (0.28 ) The following table summarizes the potential shares of common stock that were excluded from diluted net loss per share, because the effect of including these potential shares was anti-dilutive: Three Months Ended March 31, 2017 2016 Unvested restricted stock 80,070 292,466 Stock options 916,915 768,625 Warrants 90,000 90,000
Share-based Compensation, Option and Incentive Plans Policy [Policy Text Block]	Stock-Based Compensation The Company accounts for share based payments by recognizing compensation expense based upon the estimated fair value of the awards on the date of grant. The Company determines the estimated grant-date fair value of restricted shares using quoted market prices and the grant-date fair value of stock options using the Black-Scholes option pricing model. In order to calculate the fair value of the options, certain assumptions are made regarding the components of the model, including the estimated fair value of underlying common stock, risk-free interest rate, volatility, expected dividend yield and expected option life. Changes to the assumptions could cause significant adjustments to the valuation. The Company recognizes compensation costs ratably over the period of service using the straight-line method.
Use of Estimates, Policy [Policy Text Block]	Use of Estimates The preparation of the condensed consolidated financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the amounts reported in the condensed consolidated financial statements and accompanying notes. Actual results could differ from those estimates. Items subject to significant estimates and assumptions include the allowance for doubtful accounts, share-based compensation arrangements, fair value of stock options, useful lives and realizability of long-lived assets, classification of deferred revenue and deferred franchise costs, uncertain tax positions, realizability of deferred tax assets, impairment of goodwill and intangible assets and purchase price allocations.
New Accounting Pronouncements, Policy [Policy Text Block]	Recent Accounting Pronouncements In May, 2014, 2014 09, Revenue from Contracts with Customers January 1, 2018. 2014 09 2014 09 first 2017. In February 2016, 2016 02, Leases (Topic 842). December 31, 2018. In March 2016, 2016 09, Compensation—Stock Compensation (Topic 718): January 1, 2017. In April 2016, 2016 10, Revenue from Contracts with Customers (Topic 606): two 606: 1) 2) 2014 09. In May 2016, 2016 12, Revenue from Contracts with Customers (Topic 606): 2014 09. In August 2016, 2016 15, “Statement of Cash Flows (Topic 230): December 15, 2017. In November 2016, 2016 18, Statement of Cash Flows (Topic 230): December 15, 2017, In January 2017, 2017 01, Business Combinations (Topic 805): December 15, 2017, In January 2017, 2017 04, Intangibles - Goodwill and Other (Topic 350): 2” December 15, 2019.

Note 1 - Nature of Operations20

Note 1 - Nature of Operations and Summary of Significant Accounting Policies (Tables)	3 Months Ended
	Mar. 31, 2017
Notes Tables
Schedule of Franchisor Disclosure [Table Text Block]	Three Months Ended March 31, Franchised clinics: 2017 2016 Clinics open at beginning of period 309 265 Opened or purchased during the period 18 14 Acquired during the period - - Closed during the period (1 ) (2 ) Clinics in operation at the end of the period 326 277 March 31, Company-owned or managed clinics: 2017 2016 Clinics open at beginning of period 61 47 Opened during the period - 7 Acquired during the period - - Closed or sold during the period (14 ) - Clinics in operation at the end of the period 47 54 Total clinics in operation at the end of the period 373 331 Clinic licenses sold but not yet developed 107 146
Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]	Three Months Ended March 31, 2017 2016 Net loss $ (1,647,064 ) $ (3,525,134 ) Weighted average common shares outstanding - basic 13,042,595 12,567,901 Effect of dilutive securities: Stock options - - Weighted average common shares outstanding - diluted 13,042,595 12,567,901 Basic and diluted loss per share $ (0.13 ) $ (0.28 )
Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block]	Three Months Ended March 31, 2017 2016 Unvested restricted stock 80,070 292,466 Stock options 916,915 768,625 Warrants 90,000 90,000

Note 3 - Property and Equipme21

Note 3 - Property and Equipment (Tables)	3 Months Ended
	Mar. 31, 2017
Notes Tables
Property, Plant and Equipment [Table Text Block]	March 31, December 31, 2017 2016 Office and computer equipment $ 1,099,747 $ 1,083,039 Leasehold improvements 5,085,366 5,085,366 Software developed 1,046,823 891,192 7,231,936 7,059,597 Accumulated depreciation (2,969,302 ) (2,566,172 ) 4,262,634 4,493,425 Construction in progress 98,266 231,281 $ 4,360,900 $ 4,724,706

Note 5 - Intangible Assets (Tab

Note 5 - Intangible Assets (Tables)	3 Months Ended
	Mar. 31, 2017
Notes Tables
Schedule of Intangible Assets and Goodwill [Table Text Block]	As of March 31, 2017 Gross Carrying Accumulated Net Carrying Amount Amortization Value Amortized intangible assets: Reacquired franchise rights $ 1,911,750 $ 515,136 $ 1,396,614 Customer relationships 701,000 580,584 120,416 Reacquired development rights 923,250 276,214 647,036 $ 3,536,000 $ 1,371,934 $ 2,164,066
Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block]	2017 $ 404,025 2018 439,589 2019 413,256 2020 413,256 2021 348,034 Thereafter 145,906 Total $ 2,164,066

Note 6 - Debt (Tables)

Note 6 - Debt (Tables)	3 Months Ended
	Mar. 31, 2017
Notes Tables
Schedule of Maturities of Long-term Debt [Table Text Block]	2017 $ 168,000 Thereafter - Total $ 168,000

Note 7 - Equity (Tables)

Note 7 - Equity (Tables)	3 Months Ended
	Mar. 31, 2017
Notes Tables
Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]	Three Months Ended March 31, 2017 2016 Expected volatility 42% 44% - 45% Expected dividends None None Expected term (years) 7 7 Risk-free rate 2.10% to 2.14% 1.50% - 1.68% Forfeiture rate 20% 20%
Share-based Compensation, Stock Options, Activity [Table Text Block]	Number of Weighted Weighted Weighted Outstanding at December 31, 2016 953,075 $ 3.66 $ 1.86 6.9 Granted at market price 40,000 3.00 Exercised (59,142 ) 1.20 Cancelled (17,018 ) 5.10 Outstanding at March 31, 2017 916,915 $ 3.76 $ 1.78 7.0 Exercisable at March 31, 2017 345,855 $ 4.59 $ 2.24 4.4
Schedule of Share-based Compensation, Restricted Stock and Restricted Stock Units Activity [Table Text Block]	Restricted Stock Awards Shares Outstanding at December 31, 2016 92,415 Awards granted - Awards vested - Awards forfeited (12,345 ) Outstanding at March 31, 2017 80,070
Class of Treasury Stock [Table Text Block]	Year 1 $ 0.56 Year 2 $ 0.68 Year 3 $ 0.84 Year 4 $ 1.03 Year 5 $ 1.28 Year 6 $ 1.59 Year 7 $ 1.97 Year 8 $ 2.45

Note 10 - Commitments and Con25

Note 10 - Commitments and Contingencies (Tables)	3 Months Ended
	Mar. 31, 2017
Notes Tables
Schedule of Future Minimum Rental Payments for Operating Leases [Table Text Block]	2017 (remaining) $ 1,814,011 2018 1,855,661 2019 1,536,117 2020 1,264,664 2021 1,122,612 Thereafter 3,923,358 Total $ 11,516,423

Note 11 - Segment Reporting (Ta

Note 11 - Segment Reporting (Tables)	3 Months Ended
	Mar. 31, 2017
Notes Tables
Schedule of Segment Reporting Information, by Segment [Table Text Block]	Three Months Ended March 31, 2017 2016 Revenues: Corporate clinics $ 2,497 $ 1,659 Franchise operations 3,177 2,606 Total revenues $ 5,674 $ 4,265 Segment operating (loss) income: Corporate clinics $ (599 ) $ (1,694 ) Franchise operations 1,351 989 Total segment operating (loss) income $ 752 $ (705 ) Depreciation and amortization: Corporate clinics $ 444 $ 493 Franchise operations - - Corporate administration 134 83 Total depreciation and amortization $ 578 $ 576 Reconciliation of total segment operating income (loss) to consolidated earnings (loss) before income taxes (in thousands): Total segment operating (loss) income $ 752 $ (705 ) Unallocated corporate (2,339 ) (2,776 ) Consolidated loss from operations (1,587 ) (3,481 ) Other (expense) income, net (19 ) - Loss before income tax expense $ (1,606 ) $ (3,481 )
Reconciliation of Assets from Segment to Consolidated [Table Text Block]	March 31, December 31, 2017 2016 Segment assets: Corporate clinics $ 10,301 $ 10,481 Franchise operations 1,894 2,003 Total segment assets $ 12,195 $ 12,484 Unallocated cash and cash equivalents and restricted cash $ 2,989 $ 3,344 Unallocated property and equipment 680 781 Other unallocated assets 609 446 Total assets $ 16,473 $ 17,055

Supplemental Disclosure of No27

Supplemental Disclosure of Non-cash Information (Details Textual) - USD ($)	3 Months Ended
	Mar. 31, 2017	Mar. 31, 2016
Income Taxes Paid	$ 5,875	$ 3,625
Interest Paid	$ 30,161	2,648
Accounts Payable [Member]
Capital Expenditures Incurred but Not yet Paid		796,581
Accrued Expenses [Member]
Capital Expenditures Incurred but Not yet Paid		$ 147,186

Note 1 - Nature of Operations28

Note 1 - Nature of Operations and Summary of Significant Accounting Policies (Details Textual)	3 Months Ended		12 Months Ended
	Mar. 31, 2017USD ($)	Mar. 31, 2016USD ($)	Dec. 31, 2016USD ($)
Number of PC Entities	3
Number of Franchises			5
Allowance for Doubtful Accounts Receivable	$ 131,830		$ 131,830
Franchise Monthly Marketing Fee Gross Sales Percentage	2.00%
Lease Exit Liability	$ 700,000
Regional Developers License Fee	$ 7,250
Regional Developers License Fee Current Franchise Fee Percentage	25.00%
Regional Developers Royalty Sales Generated by Franchises Percentage	3.00%
Franchise Royalty Gross Sales Percentage	7.00%
Advertising Expense	$ 286,415	$ 422,098
Liability for Uncertainty in Income Taxes, Current	40,000		40,000
Goodwill, Impairment Loss	0	0
Impairment of Long-Lived Assets Held-for-use	0	$ 0
Cash Equivalents, at Carrying Value	0		0
Other Liabilities [Member]
Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued	27,000		$ 27,000
Regional Development Agreement [Member]
Deferred Revenue	$ 650,000
Computer Software, Intangible Asset [Member]
Finite-Lived Intangible Asset, Useful Life	5 years
Development Rights [Member]
Finite-Lived Intangible Asset, Useful Life	7 years
Customer Relationships [Member]
Finite-Lived Intangible Asset, Useful Life	2 years
Minimum [Member]
Property, Plant and Equipment, Useful Life	3 years
Regional Developers, Franchise Fees Collected Upon Sale of Franchise	$ 14,500
Minimum [Member] | Franchise Rights [Member]
Finite-Lived Intangible Asset, Useful Life	6 years
Maximum [Member]
Property, Plant and Equipment, Useful Life	7 years
Regional Developers, Franchise Fees Collected Upon Sale of Franchise	$ 19,950
Maximum [Member] | Franchise Rights [Member]
Finite-Lived Intangible Asset, Useful Life	8 years
Customer Concentration Risk [Member] | Accounts Receivable [Member] | Three PC Entities [Member]
Concentration Risk, Percentage	28.00%
Customer Concentration Risk [Member] | Accounts Receivable [Member] | Five Franchisees [Member]
Concentration Risk, Percentage			24.00%
Customer Concentration Risk [Member] | Sales Revenue, Net [Member]
Number of Major Customers	0	0

Note 1 - Nature of Operations29

Note 1 - Nature of Operations and Summary of Significant Accounting Policies - Clinics in Operation Under Franchise Agreements or Company-owned or Managed (Details)	3 Months Ended
	Mar. 31, 2017	Mar. 31, 2016	Mar. 31, 2017	Mar. 31, 2016
Clinics in operation at the end of the period	373	331
Number of Stores	373	331	373	331
Clinic licenses sold but not yet developed			107	146
Franchised Units [Member]
Clinics open at beginning of period	309	265
Opened or purchased during the period	18	14
Acquired during the period
Closed during the period	(1)	(2)
Clinics in operation at the end of the period	326	277
Acquired during the period
Number of Stores	309	265	326	277
Entity Operated Units [Member]
Clinics open at beginning of period	61	47
Opened or purchased during the period		7
Acquired during the period
Closed during the period	(14)
Clinics in operation at the end of the period	47	54
Acquired during the period
Number of Stores	61	47	47	54

Note 1 - Nature of Operations30

Note 1 - Nature of Operations and Summary of Significant Accounting Policies - Earnings (Loss) Per Common Share (Details) - USD ($)	3 Months Ended
	Mar. 31, 2017	Mar. 31, 2016
Net loss	$ (1,647,064)	$ (3,525,134)
Weighted average common shares outstanding - basic (in shares)	13,042,595	12,567,901
Effect of dilutive securities:
Stock options (in shares)
Weighted average common shares outstanding - diluted (in shares)	13,042,595	12,567,901
Basic and diluted loss per share (in dollars per share)	$ (0.13)	$ (0.28)

Note 1 - Nature of Operations31

Note 1 - Nature of Operations and Summary of Significant Accounting Policies - Potential Shares of Common Stock Excluded from Diluted Net Loss Per Share (Details) - shares	3 Months Ended
	Mar. 31, 2017	Mar. 31, 2016
Restricted Stock [Member]
Anti-dilutive Securities (in shares)	80,070	292,466
Employee Stock Option [Member]
Anti-dilutive Securities (in shares)	916,915	768,625
Warrant [Member]
Anti-dilutive Securities (in shares)	90,000	90,000

Note 2 - Notes Receivable (Deta

Note 2 - Notes Receivable (Details Textual)	1 Months Ended
	May 31, 2016USD ($)	Jul. 31, 2015USD ($)	Jul. 31, 2012USD ($)	Mar. 31, 2017USD ($)	Dec. 31, 2016USD ($)
Non-interest Bearing Unsecured Promissory Note 1 [Member]
Financing Receivable, Net		$ 10,000
Non-interest Bearing Unsecured Promissory Note 2 [Member]
Financing Receivable, Net		$ 29,925
Notes Receivable, Contractual Term		2 years
Non-interest Bearing Unsecured Promissory Note Maturing October 1, 2017 [Member]
Financing Receivable, Net	$ 7,500
Notes Receivable, Contractual Term	180 days
Number of License Transfer Agreements	3
Number of Unsecured Promissory Notes	3
Company-owned Clinic [Member]
Financing Receivable, Net			$ 90,000	$ 30,818	$ 40,826
Notes Receivable, Interest Rate			6.00%
Notes Receivable, Contractual Term			4 years 180 days
Notes Receivable, Principal and Interest, Term			3 years 180 days
Number of License Transfer Agreements		2

Note 3 - Property and Equipme33

Note 3 - Property and Equipment (Details Textual)	1 Months Ended	3 Months Ended
	Dec. 31, 2016USD ($)	Mar. 31, 2017USD ($)	Mar. 31, 2016USD ($)
Depreciation		$ 403,131	$ 401,867
Loss on Disposition or Impairment [Member]
Impairment of Long-Lived Assets to be Disposed of	$ 2,400,000
Corporate Clinics [Member]
Number of Clinics Classified as Held for Sale	14

Note 3 - Property and Equipme34

Note 3 - Property and Equipment - Summary of Property and Equipment (Details) - USD ($)	Mar. 31, 2017	Dec. 31, 2016
Property and equipment, gross	$ 7,231,936	$ 7,059,597
Accumulated depreciation	(2,969,302)	(2,566,172)
Property and equipment, net	4,360,900	4,724,706
Construction in progress	98,266	231,281
Office Equipment [Member]
Property and equipment, gross	1,099,747	1,083,039
Leasehold Improvements [Member]
Property and equipment, gross	5,085,366	5,085,366
Software Development [Member]
Property and equipment, gross	1,046,823	891,192
Property Plant and Equipment, Excluding Construction in Progress [Member]
Property and equipment, net	$ 4,262,634	$ 4,493,425

Note 4 - Fair Value Considera35

Note 4 - Fair Value Consideration (Details Textual) - USD ($) $ in Thousands	Mar. 31, 2017	Dec. 31, 2016
Financial Instruments, Owned, at Fair Value	$ 0	$ 0

Note 5 - Intangible Assets (Det

Note 5 - Intangible Assets (Details Textual) - USD ($)	3 Months Ended
	Mar. 31, 2017	Mar. 31, 2016
Amortization of Intangible Assets	$ 174,856	$ 173,677

Note 5 - Intangible Assets - In

Note 5 - Intangible Assets - Intangible Assets Acquired (Details)	Mar. 31, 2017USD ($)
Gross Carrying Amount	$ 3,536,000
Accumulated Amortization	1,371,934
Net Carrying Value	2,164,066
Franchise Rights [Member]
Gross Carrying Amount	1,911,750
Accumulated Amortization	515,136
Net Carrying Value	1,396,614
Customer Relationships [Member]
Gross Carrying Amount	701,000
Accumulated Amortization	580,584
Net Carrying Value	120,416
Development Rights [Member]
Gross Carrying Amount	923,250
Accumulated Amortization	276,214
Net Carrying Value	$ 647,036

Note 5 - Intangible Assets - Es

Note 5 - Intangible Assets - Estimated Amortization Expense (Details)	Mar. 31, 2017USD ($)
2,017	$ 404,025
2,018	439,589
2,019	413,256
2,020	413,256
2,021	348,034
Thereafter	145,906
Total	$ 2,164,066

Note 6 - Debt (Details Textual)

Note 6 - Debt (Details Textual)	Jan. 03, 2017USD ($)	Dec. 31, 2016USD ($)	Dec. 31, 2015USD ($)	Mar. 31, 2017USD ($)
Number of Notes Payable Delivered as a Portion of the Consideration Paid in Connection With Acquisitions		2	12
Revolving Credit Facility [Member]
Debt Instrument, Interest Rate, Stated Percentage	10.00%
Line of Credit Facility, Maximum Borrowing Capacity	$ 5,000,000
Line of Credit Facility, Minimum Interest Payment Over Life of Credit Agreement	200,000
Line of Credit Facility, Periodic Payment, Interest	$ 25,000
Long-term Line of Credit				$ 1,000,000
Notes Payable Delivered as a Portion of the Consideration Paid in Connection With Acquisitions [Member]
Debt Instrument, Face Amount		$ 186,000	$ 800,350
Debt Instrument, Interest Rate, Stated Percentage		4.25%
Notes Payable Delivered as a Portion of the Consideration Paid in Connection With Acquisitions [Member] | Minimum [Member]
Debt Instrument, Interest Rate, Stated Percentage			1.50%
Notes Payable Delivered as a Portion of the Consideration Paid in Connection With Acquisitions [Member] | Maximum [Member]
Debt Instrument, Interest Rate, Stated Percentage			5.25%

Note 6 - Debt - Maturities of N

Note 6 - Debt - Maturities of Notes Payable (Details)	Mar. 31, 2017USD ($)
2,017	$ 168,000
Total	$ 168,000

Note 7 - Equity (Details Textua

Note 7 - Equity (Details Textual) - USD ($)	1 Months Ended		3 Months Ended
	Dec. 31, 2016	Dec. 31, 2013	Mar. 31, 2017	Mar. 31, 2016
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross			40,000
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value			$ 1,021,554
Stock Repurchased During Period, Shares		534,000
Share Price		$ 0.45
Stock Repurchased During Period, Value		$ 240,000
Treasury Stock, Retired, Cost Method, Amount		$ 791,638
Binomial Lattice-based Model, Fair Value, Share Price	$ 1.03
Binomial Lattice-based Model, Fair Value, Total	$ 551,638
Stock Issued During Period, Shares, Treasury Stock Reissued	250,872
Stock Issued During Period, Value, Treasury Stock Reissued	$ 210,000
Treasury Stock [Member]
Stock Issued During Period, Value, Treasury Stock Reissued	113,000
Common Stock [Member]
Option to Repurchase Shares, Change in Fair Value	(259,000)
Additional Paid-in Capital [Member]
Stock Issued During Period, Value, Treasury Stock Reissued	$ 162,000
Employee Stock Option [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross			40,000
Allocated Share-based Compensation Expense			$ 51,038	$ 107,506
Employee Service Share-based Compensation, Nonvested Awards, Compensation Not yet Recognized, Stock Options			$ 686,052
Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized, Period for Recognition			3 years 36 days
Share-based Compensation Arrangement by Share-based Payment Award, Expiration Period		8 years
Restricted Stock [Member]
Allocated Share-based Compensation Expense			$ 44,027	$ 90,163
Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized, Period for Recognition			1 year 182 days
Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized			$ 73,672
Minimum [Member]
Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Exercise Price			$ 2.65
Maximum [Member]
Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Exercise Price			$ 3.11

Note 7 - Equity - Fair Value As

Note 7 - Equity - Fair Value Assumptions of Options Granted (Details) - Employee Stock Option [Member]	3 Months Ended
	Mar. 31, 2017	Mar. 31, 2016
Expected volatility	42.00%
Expected dividends	0.00%	0.00%
Expected term (years) (Year)	7 years	7 years
Forfeiture rate	20.00%	20.00%
Minimum [Member]
Expected volatility		44.00%
Expected term (years) (Year)
Risk-free rate	2.10%	1.50%
Maximum [Member]
Expected volatility		45.00%
Expected term (years) (Year)
Risk-free rate	2.14%	1.68%

Note 7 - Equity - Stock Options

Note 7 - Equity - Stock Options Activity (Details) - $ / shares	3 Months Ended	12 Months Ended
	Mar. 31, 2017	Dec. 31, 2016
Granted at Market Price, Number of Shares (in shares)	40,000
Employee Stock Option [Member]
Outstanding, Number of Shares (in shares)	953,075
Outstanding, Weighted Average Exercise Price (in dollars per share)	$ 3.66
Outstanding, Weighted Average Fair Value (in dollars per share)	$ 1.78	$ 1.86
Outstanding, Weighted Average Remaining Contractual Life (Year)	7 years	6 years 328 days
Granted at Market Price, Number of Shares (in shares)	40,000
Granted at Market Price, Weighted Average Exercise Price (in dollars per share)	$ 3
Exercised, Number of Shares (in shares)	(59,142)
Exercised, Weighted Average Exercise Price (in dollars per share)	$ 1.20
Cancelled, Number of Shares (in shares)	(17,018)
Cancelled, Weighted Average Exercise Price (in dollars per share)	$ 5.10
Outstanding, Number of Shares (in shares)	916,915	953,075
Outstanding, Weighted Average Exercise Price (in dollars per share)	$ 3.76	$ 3.66
Exercisable, Number of Shares (in shares)	345,855
Exercisable, Weighted Average Exercise Price (in dollars per share)	$ 4.59
Exercisable, Weighted Average Fair Value (in dollars per share)	$ 2.24
Exercisable, Weighted Average Remaining Contractual Life (Year)	4 years 146 days

Note 7 - Equity - Restricted St

Note 7 - Equity - Restricted Stock Activity (Details) - Restricted Stock [Member]	3 Months Ended
	Mar. 31, 2017shares
Unvested (in shares)	92,415
Awards granted (in shares)
Awards vested (in shares)
Awards forfeited (in shares)	(12,345)
Unvested (in shares)	80,070

Note 7 - Equity - Stock Repurch

Note 7 - Equity - Stock Repurchase Option (Details)	Dec. 31, 2013$ / shares
Year 1 (in dollars per share)	$ 0.56
Year 2 (in dollars per share)	0.68
Year 3 (in dollars per share)	0.84
Year 4 (in dollars per share)	1.03
Year 5 (in dollars per share)	1.28
Year 6 (in dollars per share)	1.59
Year 7 (in dollars per share)	1.97
Year 8 (in dollars per share)	$ 2.45

Note 8 - Income Taxes (Details

Note 8 - Income Taxes (Details Textual) - USD ($)	3 Months Ended
	Mar. 31, 2017	Mar. 31, 2016
Income Tax Expense (Benefit)	$ 40,609	$ 44,397

Note 9 - Related Party Transa47

Note 9 - Related Party Transactions (Details Textual) - USD ($)	3 Months Ended
	Mar. 31, 2017	Mar. 31, 2016
Related Party Transaction, Amounts of Transaction	$ 52,000	$ 110,000

Note 10 - Commitments and Con48

Note 10 - Commitments and Contingencies (Details Textual) - USD ($)	3 Months Ended
	Mar. 31, 2017	Mar. 31, 2016
Operating Leases, Rent Expense, Net	$ 744,295	$ 752,495

Note 10 - Commitments and Con49

Note 10 - Commitments and Contingencies - Summary of Future Minimum Rental Payments for Operating Leases (Details)	Mar. 31, 2017USD ($)
2017 (remaining)	$ 1,814,011
2,018	1,855,661
2,019	1,536,117
2,020	1,264,664
2,021	1,122,612
Thereafter	3,923,358
Total	$ 11,516,423

Note 11 - Segment Reporting (De

Note 11 - Segment Reporting (Details Textual)	3 Months Ended
	Mar. 31, 2017USD ($)	Mar. 31, 2016
Number of Operating Segments	2
Number of Stores	373	331
Number of Reportable Segments	2
The 12 Months Ended December 31, 2016 [Member] | Reclassified from Other Unallocated Assets to Corporate Clinics Segment Assets [Member]
Prior Period Reclassification Adjustment	$ 545,000
Corporate Clinics [Member]
Number of Stores	47
Franchise Operations [Member]
Number of Stores	326

Note 11 - Segment Reporting - S

Note 11 - Segment Reporting - Segment Reporting Financial Information (Details) - USD ($)	3 Months Ended
	Mar. 31, 2017	Mar. 31, 2016
Revenues	$ 5,673,857	$ 4,265,036
Operating income (loss)	(1,586,990)	(3,481,210)
Depreciation and amortization	577,987	575,544
Other (expense) income, net	(19,465)	473
Loss before income tax expense	(1,606,455)	(3,480,737)
Operating Segments [Member]
Operating income (loss)	752,000	(705,000)
Corporate, Non-Segment [Member]
Operating income (loss)	(2,339,000)	(2,776,000)
Corporate Clinics [Member]
Revenues	2,497,000	1,659,000
Operating income (loss)	(599,000)	(1,694,000)
Depreciation and amortization	444,000	493,000
Franchise Operations [Member]
Revenues	3,177,000	2,606,000
Operating income (loss)	1,351,000	989,000
Depreciation and amortization
Corporate Segment [Member]
Depreciation and amortization	$ 134,000	$ 83,000

Note 11 - Segment Reporting -52

Note 11 - Segment Reporting - Segment Reporting Information, Assets (Details) - USD ($)	Mar. 31, 2017	Dec. 31, 2016	Mar. 31, 2016	Dec. 31, 2015
Total assets	$ 16,473,138	$ 17,054,861
Unallocated cash and cash equivalents and restricted cash	2,676,607	3,009,864	$ 10,367,496	$ 16,792,850
Unallocated property and equipment	4,360,900	4,724,706
Operating Segments [Member]
Total assets	12,195,000	12,484,000
Unallocated cash and cash equivalents and restricted cash	2,989,000	3,344,000
Unallocated property and equipment	680,000	781,000
Other unallocated assets	609,000	446,000
Corporate Clinics [Member]
Total assets	10,301,000	10,481,000
Franchise Operations [Member]
Total assets	$ 1,894,000	$ 2,003,000

Note 12 - Subsequent Events (De

Note 12 - Subsequent Events (Details Textual)	Apr. 29, 2017USD ($)	Mar. 31, 2017USD ($)
Subsequent Event [Member] | Promissory Note to Fund Development Fee [Member]
Debt Instrument, Interest Rate, Stated Percentage	10.00%
Debt Instrument, Term	3 years 180 days
Debt Instrument, Period Over Which Monthly Principal and Interest Payments Are Required	3 years
Regional Development Agreement [Member]
Deferred Revenue		$ 650,000
Regional Development Agreement [Member] | Subsequent Event [Member] | FLORIDA
Deferred Revenue	$ 320,000
Minimum Number of Clinics to be Opened	32
Time Frame for the Minimum Number of Clinics to be Opened	10 years